However, for a subgroup of patients with diploid, MYCN nonamplified tumors and distant metastatic disease, the INRG task force recommended an age cutoff of 12 months (365 days) for the INRG classification system [4]. This evidence concerns the gene MYCN and metastatic neoplasm.